TG Therapeutics Inc (TGTX)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
$9.70B
EV to revenue ratio (TTM)
11.71
EV to ebitda
67.14
Financial Performance
Revenue (TTM)
$0.80B
Gross profit (TTM)
$0.66B
EBITDA
$0.14B
Profitability
Operating margin (TTM)
9.02%
Profit margin
55.20%
Return on assets (TTM)
7.28%
Return on equity (TTM)
100.30%
Per Share Metrics
Revenue per share (TTM)
$5.61
EPS
$0.67
Diluted EPS (TTM)
$0.67
Book value
$4.52
Dividend per share
n/a
Dividend yield
n/a
Valuation Multiples
P/E ratio
94.60
Trailing P/E
94.60
Forward P/E
27.70
PEG ratio
1.61
Price to sales ratio (TTM)
12.13
Price to book ratio (TTM)
15.16
Growth
Quarterly earnings growth (YoY)
70.30%
Quarterly revenue growth (YoY)
-70.60%
Analyst Sentiment
Strong buy
1
Buy
6
Hold
0
Sell
0
Strong sell
1
Risk & Volatility
Beta
1.81